Most Providers Get This Wrong (And It Gets You in Trouble)

Regenerative medicine is evolving fast, but regulation hasn’t caught up.

In this talk, Robert M. Castle III breaks down what actually creates risk for providers, and it’s not the science.

From FDA claims and marketing language to informed consent and state-by-state differences, this session highlights the real factors that can put your practice at risk.

If you’re working with biologics, peptides, or regenerative therapies, understanding compliance isn’t optional, it’s ESSENTIAL.

About Robert M. Castle III:

Rob Castle is a partner in the Litigation Department at Barnes & Thornburg in Dallas, focusing primarily on healthcare law. He represents healthcare providers nationwide in matters including government investigations, compliance, billing audits, and regulatory issues. His work covers a wide range of healthcare entities, from hospitals and physician groups to pharmaceutical and medical device companies. Rob also has extensive experience with federal and state healthcare laws, including the False Claims Act, Anti-Kickback Statute, and Stark Law.

👉 Have questions about training or course options? Leave a comment below or visit https://myinjectiontraining.com/ to learn more.

#HealthcareCompliance, #FDARegulations, #MedicalLaw, #ProviderTraining, #regenerativemedicine

Our content is for informational purposes only and should not be treated as medical or health advice. Please consult with your doctor/healthcare provider if you have any questions about your medical condition.